Exact Sciences (EXAS) Tops Q2 EPS by 2c; raises guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.45), $0.02 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $622.1 million versus the consensus estimate of $601.14 million.
GUIDANCE:
Exact Sciences sees FY2023 revenue of $2.441-2.466 million, versus the consensus of $2.418 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Qualcomm investor day to detail data center plans Wednesday
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
